Edit |   |
---|---|
Antigenic Specificity | VEGF (Bevacizumab biosimilar) |
Clone | monoclonal |
Host Species | Humanized |
Reactive Species | human |
Isotype | IgG1 |
Format | Protein A/G purified, low endotoxin |
Size | 5mg |
Concentration | 1.0 - 5.0 mg/ml |
Applications | RUO |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Specificity: detects human VEGF. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Bevacizumab. Bevacizumab biosimilar is vascular endothelial growth factor directed antibody. Bevacizumab biosimilar is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions. Bevacizumab biosimilar has an approximate molecular weight of 149 kDa. Bevacizumab is produced in a mammalian cell (Chinese Hamster Ovary) expression system in a nutrient medium. |
Immunogen | n/a |
Other Names | Vascular endothelial growth factor |
Gene, Accession # | UniProt: P15692 |
Catalog # | ICH4003-5mg |
Price | $718 |
Order / More Info | VEGF (Bevacizumab biosimilar) Antibody from ICHORBIO |
Product Specific References | n/a |
U.S. OFFICE
987 Old Eagle School Rd, Ste 709
Wayne, PA 19087
us@ichor.bio